Patents by Inventor Hui Ling Tseng

Hui Ling Tseng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for inhibiting cancer cell growth
    Patent number: 9622990
    Abstract: Disclosed is a method for inhibiting cancer cell growth in a subject in need thereof, comprising administering to the subject an effective amount of a compound from Antrodia camphorata, wherein the compound is represented by formula (I): wherein R1 is a hydrogen atom or an acetyl group; and a method of inhibiting cancer cell growth by using the compound, the cancer is selected from the group consisting of lung cancer, colon cancer, prostate cancer, liver cancer and breast cancer.
    Type: Grant
    Filed: October 12, 2015
    Date of Patent: April 18, 2017
    Inventor: Hui Ling Tseng
  • Compound, extract isolated from antrodia camphorate, and method using the same
    Patent number: 9474775
    Abstract: Disclosed is a compound isolated from Antrodia camphorata, represented by formula I: wherein R1 is a hydrogen atom or an acetyl group; and a method of inhibiting cancer cell growth by using the compound, the cancer is selected from the group consisting of lung cancer, colon cancer, prostate cancer, liver cancer and breast cancer.
    Type: Grant
    Filed: August 6, 2013
    Date of Patent: October 25, 2016
    Inventor: Hui Ling Tseng
  • METHOD FOR INHIBITING CANCER CELL GROWTH
    Publication number: 20160038441
    Abstract: Disclosed is a method for inhibiting cancer cell growth in a subject in need thereof, comprising administering to the subject an effective amount of a compound from Antrodia camphorata, wherein the compound is represented by formula (I): wherein R1 is a hydrogen atom or an acetyl group; and a method of inhibiting cancer cell growth by using the compound, the cancer is selected from the group consisting of lung cancer, colon cancer, prostate cancer, liver cancer and breast cancer.
    Type: Application
    Filed: October 12, 2015
    Publication date: February 11, 2016
    Inventor: HUI LING TSENG
  • Use of compounds from in manufacturing medicaments for treating kidney diseases
    Patent number: 9249117
    Abstract: The present invention provides a use of compounds from Antrodia camphorata in manufacturing medicaments for treating kidney diseases, wherein the compounds is represented by formula (I): wherein R1 is a hydrogen atom or acetyl group, R2 is wherein the kidney disease is glomerulosclerosis or glomerulonephritis.
    Type: Grant
    Filed: February 17, 2015
    Date of Patent: February 2, 2016
    Inventor: Hui Ling Tseng
  • USE OF COMPOUNDS FROM ANTRODIA CAMPHORATA IN MANUFACTURING MEDICAMENTS FOR TREATING KIDNEY DISEASES
    Publication number: 20150336918
    Abstract: The present invention provides a use of compounds from Antrodia camphorata in manufacturing medicaments for treating kidney diseases, wherein the compounds is represented by formula (I): wherein R1 is a hydrogen atom or acetyl group, R2 is wherein the kidney disease is glomerulosclerosis or glomerulonephritis.
    Type: Application
    Filed: February 17, 2015
    Publication date: November 26, 2015
    Inventor: Hui Ling TSENG
  • COMPOUND, EXTRACT ISOLATED FROM ANTRODIA CAMPHORATE, AND METHOD USING THE SAME
    Publication number: 20140335122
    Abstract: Disclosed is a compound isolated from Antrodia camphorata, represented by formula I: wherein R1 is a hydrogen atom or an acetyl group; and a method of inhibiting cancer cell growth by using the compound, the cancer is selected from the group consisting of lung cancer, colon cancer, prostate cancer, liver cancer and breast cancer.
    Type: Application
    Filed: August 6, 2013
    Publication date: November 13, 2014
    Inventor: HUI LING TSENG
  • COMPOUND, EXTRACT ISOLATED FROM ANTRODIA CAMPHORATE, AND METHOD OF INHIBITING CANCER CELL GROWTH
    Publication number: 20140286989
    Abstract: Disclosed is a compound isolated from Antrodia camphorata, represented by formula I: wherein R1 is a hydrogen atom or an acetyl group; and a method of inhibiting cancer cell growth by using the compound, the cancer is selected from the group consisting of lung cancer, colon cancer, prostate cancer, liver cancer and breast cancer.
    Type: Application
    Filed: August 6, 2013
    Publication date: September 25, 2014
    Inventor: Hui Ling Tseng